Osage Partners

News, insights, analysis and data

← Back to Osage Partners profile

Osage Partners related stories

All articles and analysis

  • Halfpenny Tech Secures $2.6 Million in VC Funding
    Luisa Beltran- 7 October 2010

    Halfpenny Technologies has secured $2.6 million in VC funding co-led by Osage Venture Partners and Milestone Venture Partners. LORE Associates also participated in the round. Blue Bell, Pa.-based Halfpenny is a health information exchange services provider.

  • Week in deals, Sept. 27, 2010
    Brad Meikle- 27 September 2010

    Summary of tech companies and other startups in North America that raised venture financing in the past week

  • peHUB Wire: Monday, September 20, 2010
    Brad Meikle- 20 September 2010

    Risky Business

  • peHUB Wire: Monday, September 20, 2010
    Brad Meikle- 20 September 2010

    Risky Business

  • peHUB Wire: Friday, September 17, 2010
    Brad Meikle- 17 September 2010

    Friday Feedback

  • peHUB Wire: Friday, September 17, 2010
    Brad Meikle- 17 September 2010

    Friday Feedback

  • InstaMed Secures $6 Million in Growth Capital
    VCJ Staff- 16 September 2010

    InstaMed raised $6 million in growth capital. The financing came from existing investors who with this round have invested a total of $22 million. The Philadelphia, Pa.–based provider of a healthcare payments network and platform’s investors include Osage Partners, Ashby Point Capital, NJTC Venture Fund, U.S. Bank, N.A. and a private equity group in Newport Beach, Calif.

  • Field View Solutions Raises $2.75 Million
    VCJ Staff- 17 December 2009

    Field View Solutions, an Edison, N.J.-based provider of enterprise software for data center managers, has raised $2.75 million in Series A funding. SJF Ventures led the round, and was joined by Milestone Venture Partners and Osage Partners.

  • Week in deals, Nov. 9, 2009
    Brad Meikle- 9 November 2009

    Summary of North American tech companies and other startups that raised venture financing in the past week

  • Virdante Pharma Raises $47 Million
    VCJ Staff- 29 October 2009

    Virdante Pharmaceuticals, a Cambridge, Mass.-based developer of technology to increase the anti-inflammatory potency of plasma-derived intravenous immune globulin, has expanded its Series A funding to $47.75 million. Thomas, McNerney & Partners led the new tranche, and was joined by Osage Partners and return backers Clarus Ventures, Venrock, MedImmune Ventures and Biogen Idec New Ventures.